Skip to content

Elobixibat Versus First Dose of Split High-volume Polyethylene Glycol For Bowel Preparation: A Randomized Controlled Trial

Elobixibat Versus First Dose of Split High-volume Polyethylene Glycol For Bowel Preparation: A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20241022003
Enrollment
170
Registered
2024-10-22
Start date
2024-05-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Person who underwent elective colonoscopy Colonoscopy, bowel preparation, elobixibat, polyethylen glycol

Interventions

Bowel preparation with Elobixibat 10 mg day before colonoscopy PEG 2 Litres day of colonoscopy,Bowel preparation with PEG 2 Litres day before colonoscopy, PEG 2 Litres day of colonoscopy
Active Comparator Drug,Active Comparator Drug
Elobixibat &amp
PEG 2-L,PEG 4-L split dose

Sponsors

The Gastroenterological Association of Thailand (GAT)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age >18 years 2.Elective colonoscopy

Exclusion criteria

Exclusion criteria: 1.Suspected bowel obstruction 2.Suspected or known case of inflammatory bowel disease 3.History of gastrointestinal surgery apart from appendectomy or cholecystectomy 4.History of pelvic surgery 5.Severe cardiac or pulmonary disease (American Society of Anesthesiologists physical status class 3 or 4), severe renal failure (creatinine clearance < 15 ml/min), decompensated liver cirrhosis (Child pugh score > 9), Advanced stage of malignancy 6.Compromised swallowing reflex or impaired mental status 7.Pregnancy or lactating 8.Hypersensitivity to PEG or Elobixibat

Design outcomes

Primary

MeasureTime frame
Quality of bowel preparation at colonoscopy session Boston bowel preparation score

Secondary

MeasureTime frame
Adverse event after bowel preparation Present of abdominal pain, nausea, vomitting, sleep disturbance

Countries

Thailand

Contacts

Public ContactAraya Ungamrung

Faculty of Medicine Vajira Hospital, Navamindradhiraj University

art_doxfan@hotmail.com0857000288

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026